Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2012
03/20/2012CA2579840C Carboxamide spirolactam cgrp receptor antagonists
03/20/2012CA2524900C 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
03/20/2012CA2505029C Isoindoline derivatives
03/20/2012CA2489526C Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
03/20/2012CA2453510C Treatment of fatigue and cognitive side effects associated with cancer, cancer treatments and menopause with d-threo-methyphenidate
03/20/2012CA2446872C Immune-modulating peptide
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/16/2012CA2752131A1 Novel derivatives of dihydrobenzoxathiazepines, their preparation process and pharmaceutical compositions containing them
03/15/2012WO2012034101A2 Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
03/15/2012WO2012033789A2 Treatment of diseases
03/15/2012WO2012033435A1 Method, compound, pharmaceutical composition and drug for restoring memory lost in normal and pathological contexts
03/15/2012WO2012033329A2 Composition containing oenanthe javanica extract as an active ingredient for preventing or treating learning disabilities or memory disorders, and method for preparing same
03/15/2012WO2012033235A1 Pharmaceutical composition for treating anxiety disorder, containing n-acetyl-l-cysteine or derivative thereof
03/15/2012WO2012033070A1 Therapeutic agent for pain
03/15/2012WO2012032334A1 Quinoline and quinoxaline derivatives as kinase inhibitors
03/15/2012WO2012031993A1 Novel n-hydroxy-benzamides for the treatment of cancer
03/15/2012WO2012031941A2 2-(R²-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINE FOR TREATING A β-AMYLOIDOPATHY OR AN ALPHA-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
03/15/2012WO2012031383A1 Amide compounds
03/15/2012WO2012031328A1 Treatments for substance abuse and addiction
03/15/2012WO2012031327A1 Modified relaxin polypeptides
03/15/2012WO2012031326A1 Single chain relaxin polypeptides
03/15/2012WO2012007555A3 New ziprasidone salts and methods of their formation
03/15/2012WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/15/2012WO2011160845A3 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment
03/15/2012WO2011146589A8 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
03/15/2012WO2011143229A3 Lipid compositions and structured lipids containing phospholipids, oral formulations containing the same and methods of making the same
03/15/2012WO2011131748A3 Benzimidazole derivatives as inhibitors of glutaminyl cyclase
03/15/2012WO2011112893A3 Compositions for ameliorating cell proliferative disorders and methods of making and using them
03/15/2012US20120066775 Stresscopins and their Uses
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120065265 Alpha-2-delta ligands for non-restorative sleep
03/15/2012US20120065259 Heat assisted lidocaine and tetracaine for transdermal analgesia
03/15/2012US20120065257 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
03/15/2012US20120065241 Therapeutic compounds for diseases and disorders
03/15/2012US20120065240 Method for treating nervous system disorders and conditions
03/15/2012US20120065237 Methods for treating transthyretin amyloid diseases
03/15/2012US20120065234 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
03/15/2012US20120065231 Thiophene derivative
03/15/2012US20120065227 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
03/15/2012US20120065225 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
03/15/2012US20120065223 Solid forms of a chemokine receptor antagonist and methods of use thereof
03/15/2012US20120065221 Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
03/15/2012US20120065220 Tamper Resistant Dosage Form Comprising An Anionic Polymer
03/15/2012US20120065219 Spirocyclic azaadamantane derivatives and methods of use
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065213 C-met protein kinase inhibitors
03/15/2012US20120065211 Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
03/15/2012US20120065205 Pyrazine carboxamide orexin receptor antagonists
03/15/2012US20120065202 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/15/2012US20120065198 Detection and Treatment of Schizophrenia
03/15/2012US20120065195 Compounds for treating neurodegenerative diseases
03/15/2012US20120065194 Use of cyproheptadine to treat organophosphate exposure
03/15/2012US20120065193 Cyclopropyl Amide Derivatives '978
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065190 Benzazepine compounds as cgrp receptor antagonists
03/15/2012US20120065189 Heterocyclic compounds for the treatment of stress-related conditions
03/15/2012US20120065184 Compounds and compositions as trk inhibitors
03/15/2012US20120065183 Tetrahydro-Pyrido-Pyrimidine Derivatives
03/15/2012US20120065181 Method of providing neuroprotection using substituted porphyrins
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065172 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
03/15/2012US20120065162 N-n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
03/15/2012US20120065152 Prodrugs of guanfacine
03/15/2012US20120065150 Neuroprotective effects of 2DG in Traumatic Brain Injury
03/15/2012US20120065142 Novel solid materials of and methods for obtaining them
03/15/2012US20120065141 Stabilized biodegradable neurotoxin implants
03/15/2012US20120065131 Compositions and methods for topical application and transdermal delivery of an oligopeptide
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064598 Mutation of the parkin gene, compositions, methods and uses
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064181 P2X3 Receptor Antagonists for Treatment of Pain
03/15/2012US20120064179 Bicarbonate solution for bioavailable magnesium and uses thereof
03/15/2012US20120064168 Methods of treatment using a gastric retained gabepentin dosage
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064152 Analgesic and Anti-Inflammatory Compositions Comprising Domperidone and Methods of Using Same
03/15/2012US20120064149 High-clarity aqueous concentrates of 4-hexylresorcinol
03/15/2012US20120064147 Agent for improving tissue penetration
03/15/2012US20120064143 Inhibition of mammalian target of rapamycin
03/15/2012US20120064142 Polymeric pharmaceutical dosage form in sustained release
03/15/2012US20120064133 Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations
03/15/2012US20120064130 Method for impregnation with supercritical co2
03/15/2012US20120064129 Gastric retained gabapentin dosage form
03/15/2012US20120064127 Composition for improving membrane composition and functioning of cells
03/15/2012US20120064122 Treatment of autoimmune inflammation using mir-155
03/15/2012US20120064121 Pyridine compounds for inflammation and immune-related uses
03/15/2012US20120064099 Compounds that inhibit nfkb and bace1 activity
03/15/2012US20120064094 Serotonin 5-HT3 Receptor Antagonists for Use in the Treatment of Lesional Vestibular Disorders
03/15/2012US20120064091 Dysfunction of the mitochondrial respiratory chain, methods for diagnosis, treatment and follow-up
03/15/2012US20120064065 Safe and functional humanized antibodies
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012US20120064059 Fusion proteins
03/15/2012US20120064054 Pharmaceutical compositions active in preventing, stabilizing and treating alzheimer's disease
03/15/2012US20120064048 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
03/15/2012US20120064041 Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof
03/15/2012US20120064031 Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
03/15/2012US20120064030 Methods of treating nervous system conditions
03/15/2012US20120064029 Compositions for treating nervous system conditions
03/15/2012US20120064028 Pregnancy-Induced Oligodendrocyte Precursor Cell Proliferation Regulated by Prolactin
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 1833